GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ascendis Health Ltd (JSE:ASC) » Definitions » Debt-to-Revenue

Ascendis Health (JSE:ASC) Debt-to-Revenue : 0.03 (As of Jun. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Ascendis Health Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Ascendis Health's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was R31 Mil. Ascendis Health's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was R19 Mil. Ascendis Health's annualized Revenue for the quarter that ended in Jun. 2023 was R1,516 Mil. Ascendis Health's annualized Debt-to-Revenue for the quarter that ended in Jun. 2023 was 0.03.


Ascendis Health Debt-to-Revenue Historical Data

The historical data trend for Ascendis Health's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ascendis Health Debt-to-Revenue Chart

Ascendis Health Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.00 3.28 3.83 0.45 0.03

Ascendis Health Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.63 0.40 0.44 0.13 0.03

Competitive Comparison of Ascendis Health's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Ascendis Health's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ascendis Health's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ascendis Health's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Ascendis Health's Debt-to-Revenue falls into.



Ascendis Health Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Ascendis Health's Debt-to-Revenue for the fiscal year that ended in Jun. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(31.231 + 19.306) / 1535.437
=0.03

Ascendis Health's annualized Debt-to-Revenue for the quarter that ended in Jun. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(31.231 + 19.306) / 1516.446
=0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is two times the quarterly (Jun. 2023) Revenue data.


Ascendis Health Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Ascendis Health's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Ascendis Health (JSE:ASC) Business Description

Traded in Other Exchanges
N/A
Address
1 Carey Street, Wynberg, Sandton, GT, ZAF, 2090
Ascendis Health is a drug manufacturer that produces and distributes health products for the human, animal, and plant markets. It has a portfolio of brands and products and owns recognized trademarks in the pharmaceutical and consumer health markets. Ascendis Health has five operating segments: consumer health, pharma, medical, animal health, and biosciences. The pharma division is the contributor to revenue and is further divided into Pharma Africa, Remedica, and Farmalider. Pharma includes generic manufacturing and distribution and over-the-counter medicine manufacturing and distribution. The company's revenue is split between South Africa and Europe and is diversified across currencies, markets, sales channels, and customer groups.